Skip to main content

Advertisement

SpringerLink
Log in

Pathogenesis of chronic allograft rejection

  • Review Article
  • Published:
Transplant International

Abstract

Chronic allograft nephropathy (CAN) is, besides death of the recipient with graft function, the most common cause of renal transplant loss. It is characterized by loss of function and replacement of tissue by fibrotic material. The pathogenesis is not clear, but seems to be multifactorial and involves events both early and late after transplantation. Alloantigen-dependent mechanisms seem to be crucial for the development of chronic rejection (CR). Although modern immunosuppressive drugs have reduced the number and severity of acute rejection episodes, their effects on CR are less obvious. In this review we discuss the role of direct and indirect antigen presentation in the development of CR, and we will focus on the production of antibodies directed against HLA and non-HLA antigens on the graft and their influence on CR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Paul LC (1995) Chronic renal transplant loss. Kidney Int 47:1491–1499

    CAS  PubMed  Google Scholar 

  2. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605–612

    CAS  PubMed  Google Scholar 

  3. Pratschke J, Wilhelm MJ, Laskowski I, Kusaka M, Beato F, Tullius SG, Neuhaus P, Hancock WW, Tilney NL (2001) Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 12:2474–2481

    CAS  PubMed  Google Scholar 

  4. Stoica SC, Goddard M, Large SR (2002) The endothelium in clinical cardiac transplantation. Ann Thorac Surg 73:1002–1008

    Article  PubMed  Google Scholar 

  5. Szabo A, Heemann U (1998) Ischemia reperfusion injury and chronic allograft rejection. Transplant Proc 30:4281–4284

    CAS  PubMed  Google Scholar 

  6. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL (1998) Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 65 1533–1542

    Google Scholar 

  7. Gasser M, Waaga AM, Kist-Van Holte JE, Lenhard SM, Laskowski I, Shaw GD, Hancock WW, Tilney NL (2002) Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand. J Am Soc Nephrol 13:1937–1945

    CAS  PubMed  Google Scholar 

  8. Daemen MA, Van't Veer C, Wolfs TG, Buurman WA (1999) Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. J Immunol 162:5506–5510

    CAS  PubMed  Google Scholar 

  9. Chien CT, Lee PH, Chen CF, Ma MC, Lai MK, Hsu SM (2001) De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol 12:973–982

    CAS  PubMed  Google Scholar 

  10. Daemen MA, De Vries B, Buurman WA (2002) Apoptosis and inflammation in renal reperfusion injury. Transplantation 73:1693–1700

    CAS  PubMed  Google Scholar 

  11. Dragun D, Hoff U, Park JK, Qun Y, Schneider W, Luft FC, Haller H (2000) Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 58:2166–2177

    Article  CAS  PubMed  Google Scholar 

  12. Penfield JG, Wang Y, Li S, Kielar MA, Sicher SC, Jeyarajah DR, Lu CY(1999) Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney. Kidney Int 56:1759–1769

    Article  CAS  PubMed  Google Scholar 

  13. Waaga AM, Gasser M, Laskowski I, Tilney NL (2000) Mechanisms of chronic rejection. Curr Opin Immunol 12:517–521

    Article  CAS  PubMed  Google Scholar 

  14. Tullius SG, Hancock WW, Heemann U, Azuma H, Tilney NL (1994) Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation 58:93–99

    CAS  PubMed  Google Scholar 

  15. Tullius SG, Nieminen M, Bechstein WO, Jonas S, Steinmuller T, Qun Y, Pratschke J, Graser E, Sinha P, Volk HD, Neuhaus P, Tilney NL (1998) Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model. Kidney Int 53:465–472

    CAS  PubMed  Google Scholar 

  16. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF (1997) CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 100:279–289

    CAS  PubMed  Google Scholar 

  17. Ensminger SM, Spriewald BM, Witzke O, Pajaro OE, Yacoub MH, Morris PJ, Rose ML, Wood KJ (2002) Indirect allorecognition can play an important role in the development of transplant arteriosclerosis. Transplantation 73:279–286

    CAS  PubMed  Google Scholar 

  18. Fischbein MP, Yun J, Laks H, Irie Y, Fishbein MC, Bonavida B, Ardehali A (2002) Role of CD8+ lymphocytes in chronic rejection of transplanted hearts. J Thorac Cardiovasc Surg 123:803–809

    Article  PubMed  Google Scholar 

  19. Russell PS, Chase CM, Sykes M, Ito H, Shaffer J, Colvin RB (2001) Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 167:5731–5740

    CAS  PubMed  Google Scholar 

  20. Cramer DV, Shirwan H (1998) The importance of humoral immune responses in chronic rejection. Transplant Rev 12:166–176

    Google Scholar 

  21. Donaldson PT, Williams R (1997) Cross-matching in liver transplantation. Transplantation 63:789–794

    CAS  PubMed  Google Scholar 

  22. Russell PS, Chase CM, Winn HJ, Colvin RB (1994) Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 152:5135–5141

    CAS  PubMed  Google Scholar 

  23. Hancock WW, Buelow R, Sayegh MH, Turka LA (1998) Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 4:1392–1396

    Article  CAS  PubMed  Google Scholar 

  24. Sun H, Woodward JE, Subbotin VM, Kuddus R, Logar AJ, Schaefer AT, Aitouche A, Rao AS (2002) Use of recombinase activation gene-2 deficient mice to ascertain the role of cellular and humoral immune responses in the development of chronic rejection. J Heart Lung Transplant 21:738–750

    Article  PubMed  Google Scholar 

  25. Bian H, Harris PE, Reed EF (1998) Ligation of HLA class I molecules on smooth muscle cells with anti-HLA antibodies induces tyrosine phosphorylation, fibroblast growth factor receptor expression and cell proliferation. Int Immunol 10:1315–1323

    Article  CAS  PubMed  Google Scholar 

  26. Harris PE, Bian H, Reed EF (1997) Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis. J Immunol 159:5697–5704

    CAS  PubMed  Google Scholar 

  27. Orosz C (2002) Graft rejection: mechanism. Encyclopedia of Life Sciences

    Google Scholar 

  28. Sijpkens YW, Doxiadis II, De Fijter JW, Mallat MJ, Van Es LA, De Lange P, Zwinderman AH, Westendorp RG, Van Kemenade FJ, Bruijn JA, Claas FH, Paul LC (1999) Sharing cross-reactive groups of MHC class I improves long-term graft survival. Kidney Int 56:1920–1927

    Article  CAS  PubMed  Google Scholar 

  29. Allan JS, Madsen JC (2002) Recent advances in the immunology of chronic rejection. Curr Opin Nephrol Hypertens 11:315–321

    Article  PubMed  Google Scholar 

  30. Bradley JA, Mowat AM, Bolton EM (1992) Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection. Immunol Today 13:434–438

    CAS  PubMed  Google Scholar 

  31. Game DS, Lechler RI (2002) Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10:101–108

    Article  CAS  PubMed  Google Scholar 

  32. Sayegh MH (1999) Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 56:1967–1979

    Article  CAS  PubMed  Google Scholar 

  33. Shirwan H (1999) Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 68:715–726

    CAS  PubMed  Google Scholar 

  34. Womer KL, Stone JR, Murphy B, Chandraker A, Sayegh MH (2001) Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy. J Am Soc Nephrol 12:2500–2506

    CAS  PubMed  Google Scholar 

  35. Lechler RI, Batchelor JR (1982) Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 155:31–41

    CAS  PubMed  Google Scholar 

  36. Lee RS, Yamada K, Houser SL, Womer KL, Maloney ME, Rose HS, Sayegh MH, Madsen JC (2001) Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci U S A 98:3276–3281

    Article  CAS  PubMed  Google Scholar 

  37. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI (2001) Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 167:7199–7206

    CAS  PubMed  Google Scholar 

  38. Sayegh MH, Turka LA (1998) The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 338:1813–1821

    CAS  PubMed  Google Scholar 

  39. Dong VM, Yuan X, Coito AJ, Waaga AM, Sayegh MH, Chandraker A (2002) Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection. Transplantation 73:1310–1317

    CAS  PubMed  Google Scholar 

  40. Laskowski IA, Pratschke J, Wilhelm MJ, Dong VM, Beato F, Taal M, Gasser M, Hancock WW, Sayegh MH, Tilney NL (2002) Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol 13:519–527

    CAS  PubMed  Google Scholar 

  41. Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH (1996) Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A 93:12439–12444

    Article  CAS  PubMed  Google Scholar 

  42. Chandraker A, Azuma H, Nadeau K, Carpenter CB, Tilney NL, Hancock WW, Sayegh MH (1998) Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest 101:2309–2318

    CAS  PubMed  Google Scholar 

  43. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL (1997) The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 100:1199–1203

    CAS  PubMed  Google Scholar 

  44. Yamada AA, Sayegh MH (2002) The CD154–CD40 costimulatory pathway in transplantation. Transplantation 73:36–39

    Google Scholar 

  45. Ensminger SM, Spriewald BM, Sorensen HV, Witzke O, Flashman EG, Bushell A, Morris PJ, Rose ML, Rahemtulla A, Wood KJ (2001) Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40–CD154 costimulation. J Immunol 167:532–541

    CAS  PubMed  Google Scholar 

  46. Ensminger SM, Spriewald BM, Witzke O, Morrison K, van Maurik A, Morris PJ, Rose ML, Wood KJ (2000) Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cells. Transplantation 70:955–963

    CAS  PubMed  Google Scholar 

  47. Kishimoto K, Dong VM, Issazadeh S, Fedoseyeva EV, Waaga AM, Yamada A, Sho M, Benichou G, Auchincloss H Jr, Grusby MJ, Khoury SJ, Sayegh MH (2000) The role of CD154–CD40 versus CD28–B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 106:63–72

    CAS  PubMed  Google Scholar 

  48. Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, Fechner JH Jr, Germond RL, Kampen RL, Patterson NB, Swanson SJ, Tadaki DK, TenHoor CN, White L, Knechtle SJ, Harlan DM (1999) Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 5:686–693

    Article  CAS  PubMed  Google Scholar 

  49. Fischbein MP, Ardehali A, Yun J, Schoenberger S, Laks H, Irie Y, Dempsey P, Cheng G, Fishbein MC, Bonavida B (2000) CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J Immunol 165:7316–7322

    CAS  PubMed  Google Scholar 

  50. Guillot C, Guillonneau C, Mathieu P, Gerdes CA, Menoret S, Braudeau C, Tesson L, Renaudin K, Castro MG, Lowenstein PR, Anegon I (2002) Prolonged blockade of CD40–CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection. J Immunol 168:1600–1609

    CAS  PubMed  Google Scholar 

  51. Le Moine A, Goldman M, Abramowicz D (2002) Multiple pathways to allograft rejection. Transplantation 73:1373–1381

    PubMed  Google Scholar 

  52. Illigens B, Yamada A, Fedoseyeva E, Anosova N, Boisgerault F, Valujskikh A, Heeger P, Sayegh M, Boehm B, Benichou G (2002) The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant. Hum Immunol 63:912

    Article  CAS  PubMed  Google Scholar 

  53. Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K (1995) Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med 182:1591–1596

    CAS  PubMed  Google Scholar 

  54. Leitenberg D, Bottomly K (1999) Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol 11:283–292

    Article  CAS  PubMed  Google Scholar 

  55. Hamar P, Szabo A, Muller V, Heemann U (2001) Involvement of interleukin-2 and growth factors in chronic kidney allograft rejection in rats. Transplant Proc 33:2160–2162

    Article  CAS  PubMed  Google Scholar 

  56. Hayashi M, Martinez OM, Garcia-Kennedy R, So S, Esquivel CO, Krams SM (1995) Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 60:1533–1538

    CAS  PubMed  Google Scholar 

  57. Le Moine A, Flamand V, Demoor FX, Noel JC, Surquin M, Kiss R, Nahori MA, Pretolani M, Goldman M, Abramowicz D (1999) Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest 103:1659–1667

    PubMed  Google Scholar 

  58. Oliveira G, Xavier P, Murphy B, Neto S, Mendes A, Sayegh MH, Guerra LE (1998) Cytokine analysis of human renal allograft aspiration biopsy culture supernatants predicts acute rejection. Nephrol Dial Transplant 13:417–422

    CAS  PubMed  Google Scholar 

  59. Piccotti JR, Li K, Chan SY, Eichwald EJ, Bishop DK (1999) Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process. Transplantation 67:1548–1555

    CAS  PubMed  Google Scholar 

  60. Suthanthiran M (1997) Molecular analyses of human renal allografts: differential intragraft gene expression during rejection. Kidney Int [Suppl] 58:15–21

    Google Scholar 

  61. Raisanen-Sokolowski A, Glysing-Jensen T, Koglin J, Russell ME (1998) Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Am J Pathol 152:359–365

    CAS  PubMed  Google Scholar 

  62. Halloran PF, Miller LW, Urmson J, Ramassar V, Zhu LF, Kneteman NM, Solez K, Afrouzian M (2001) IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol 166:7072–7081

    CAS  PubMed  Google Scholar 

  63. Lu CY, Penfield JG, Kielar ML, Vazquez MA, Jeyarajah DR (1999) Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int 55:2157–2168

    Article  CAS  PubMed  Google Scholar 

  64. Vaillant B, Chiaramonte MG, Cheever AW, Soloway PD, Wynn TA (2001) Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol 167:7017–7026

    CAS  PubMed  Google Scholar 

  65. Postlethwaite AE, Holness MA, Katai H, Raghow R (1992) Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 90:1479–1485

    CAS  PubMed  Google Scholar 

  66. Ruger BM, Erb KJ, He Y, Lane JM, Davis PF, Hasan Q (2000) Interleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition. Eur J Immunol 30:2698–2703

    Article  CAS  PubMed  Google Scholar 

  67. Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H (1998) High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation 65:1072–1075

    CAS  PubMed  Google Scholar 

  68. Hutchinson IV, Alam Y, Ayliffe WR (1995) The humoral response to an allograft. Eye 9:155–160

    PubMed  Google Scholar 

  69. Kouwenhoven EA, IJzermans JN, De Bruin RW (2000) Etiology and pathophysiology of chronic transplant dysfunction. Transpl Int 13:385–401

    Article  PubMed  Google Scholar 

  70. Lederer SR, Kluth-Pepper B, Schneeberger H, Albert E, Land W, Feucht HE (2001) Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 59:334–341

    Article  CAS  PubMed  Google Scholar 

  71. Sumitran-Holgersson S (2001) HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant 16:897–904

    Article  CAS  PubMed  Google Scholar 

  72. Bohmig GA, Exner M, Watschinger B, Regele H (2002) Acute humoral renal allograft rejection. Curr Opin Urol 12:95–99

    Article  PubMed  Google Scholar 

  73. Bryan CF, Luger AM, Martinez J, Muruve N, Nelson PW, Pierce GE, Ross G, Shield CF, III, Warady BA, Aeder MI, Helling TS (2001) Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft. Transplantation 71:875–879

    CAS  PubMed  Google Scholar 

  74. Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AB, Schneeberger EE, Colvin RB (2001) Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 12:574–582

    CAS  PubMed  Google Scholar 

  75. McKenna RM, Takemoto SK, Terasaki PI (2000) Anti-HLA antibodies after solid organ transplantation. Transplantation 69:319–326

    CAS  PubMed  Google Scholar 

  76. Abe M, Kawai T, Futatsuyama K, Tanabe K, Fuchinoue S, Teraoka S, Toma H, Ota K (1997) Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation 63:1616–1619

    CAS  PubMed  Google Scholar 

  77. Piazza A, Poggi E, Borrelli L, Servetti S, Monaco PI, Buonomo O, Valeri M, Torlone N, Adorno D, Casciani CU (2001) Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques. Transplantation 71:1106–1112

    CAS  PubMed  Google Scholar 

  78. Jaramillo A, Smith MA, Phelan D, Sundaresan S, Trulock EP, Lynch JP, Cooper JD, Patterson GA, Mohanakumar T (1999) Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 67:1155–1161

    CAS  PubMed  Google Scholar 

  79. Palmer SM, Davis RD, Hadjiliadis D, Hertz MI, Howell DN, Ward FE, Savik K, Reinsmoen NL (2002) Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation 74:799–804

    CAS  PubMed  Google Scholar 

  80. McCarthy JF, Cook DJ, Massad MG, Sano Y, O'Malley KJ, Ratliff NR, Stewart RW, Smedira NG, Starling RC, Young JB, McCarthy PM (1998) Vascular rejection post heart transplantation is associated with positive flow cytometric cross-matching. Eur J Cardiothorac Surg 14:197–200

    Article  CAS  PubMed  Google Scholar 

  81. Tambur AR, Bray RA, Takemoto SK, Mancini M, Costanzo MR, Kobashigawa JA, D'Amico CL, Kanter KR, Berg A, Vega JD, Smith AL, Roggero AL, Ortegel JW, Wilmoth-Hosey L, Cecka JM, Gebel HM (2000) Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 70:1055–1059

    CAS  PubMed  Google Scholar 

  82. Susal C, Opelz G (2002) Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 73:1269–1273

    CAS  PubMed  Google Scholar 

  83. Hegde S, Mellon JK, Hargrave SL, Niederkorn JY (2002) Effect of alloantibodies on corneal allograft survival. Invest Ophthalmol Vis Sci 43:1012–1018

    Google Scholar 

  84. Supon P, Constantino D, Hao P, Cagle L, Hahn A, Conti DJ, Freed BM (2001) Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection. Transplantation 71:577–580

    CAS  PubMed  Google Scholar 

  85. Ball B, Mousson C, Ratignier C, Guignier F, Glotz D, Rifle G (2000) Antibodies to vascular endothelial cells in chronic rejection of renal allografts. Transplant Proc 32:353–354

    Article  CAS  PubMed  Google Scholar 

  86. Sumitran S (2000) Clinical importance of HLA-specific and non-HLA-specific antibodies in allogeneic kidney transplantation. Adv Nephrol Necker Hosp 30:29–39

    CAS  PubMed  Google Scholar 

  87. Perrey C, Brenchley PE, Johnson RW, Martin S (1998) An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol 6:101–106

    Article  CAS  PubMed  Google Scholar 

  88. Derhaag JG, Duijvestijn AM, Damoiseaux JG, Van Breda Vriesman P (2000) Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection. Transplantation 69:1899–1906

    CAS  PubMed  Google Scholar 

  89. Fedoseyeva EV, Zhang F, Orr PL, Levin D, Buncke HJ, Benichou G (1999) De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 162:6836–6842

    CAS  PubMed  Google Scholar 

  90. Jurcevic S, Ainsworth ME, Pomerance A, Smith JD, Robinson DR, Dunn MJ, Yacoub MH, Rose ML (2001) Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 71:886–892

    CAS  PubMed  Google Scholar 

  91. Jurcevic S, Dunn MJ, Crisp S, Busing K, Rinaldi M, Pellegrini C, Yacoub MH, Vigano M, Banner NL, Rose ML (1998) A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine. Transplantation 65:1197–1202

    CAS  PubMed  Google Scholar 

  92. Rose ML (2000) Role of antibodies in transplant-associated cardiac allograft vasculopathy. Z Kardiol 89 [Suppl 9]:11–15

    Google Scholar 

  93. Dubel L, Farges O, Sato Y, Bismuth H (1998) Development of anti-tissue antibodies in the rat liver transplant model. Transplantation 65:1135–1137

    CAS  PubMed  Google Scholar 

  94. De Heer E, Davidoff A, Van der Wal A, Van Geest M, Paul LC (1994) Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest 70:494–502

    PubMed  Google Scholar 

  95. Joosten SA, Van Dixhoorn MGA, Borrias MC, Benediktsson H, Van Veelen PA, van Kooten C, Paul LC (2002) Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am J Pathol 160:1301–1310

    CAS  PubMed  Google Scholar 

  96. Paul LC, Muralidharan J, Muzaffar SA, Manting EH, Valentin JF, De Heer E, Kashgarian M (1998) Antibodies against mesangial cells and their secretory products in chronic renal allograft rejection in the rat. Am J Pathol 152:1209–1223

    CAS  PubMed  Google Scholar 

  97. Miettinen A, Stow JL, Mentone S, Farquhar MG (1986) Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med 163:1064–1084

    CAS  PubMed  Google Scholar 

  98. Van den Born J, Van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH (1992) A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41:115–123

    PubMed  Google Scholar 

  99. Meier-Kriesche H, Ojo AO, Arndorfer JA, Magee JC, Cibrik DM, Leichtman AB, Campbell DA, Kaplan B (2001) Mycophenolate mofetil decreases the risk for chronic renal allograft failure. Transplant Proc 33:1005–1006

    Article  CAS  PubMed  Google Scholar 

  100. Mele TS, Halloran PF (2000) The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47:215–245

    Article  CAS  PubMed  Google Scholar 

  101. Meier-Kriesche HU, Ojo AO, Leichtman AB, Magee JC, Rudich SM, Hanson JA, Cibrik DM, Kaplan B (2001) Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation 71:398–401

    CAS  PubMed  Google Scholar 

  102. Ojo AO, Meier-Kriesche HU, Hanson JA, Leichtman AB, Cibrik D, Magee JC, Wolfe RA, Agodoa LY, Kaplan B (2000) Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69:2405–2409

    CAS  PubMed  Google Scholar 

  103. Rose ML, Smith J, Dureau G, Keogh A, Kobashigawa J (2002) Mycophenolate mofetil decreases antibody production after cardiac transplantation. J Heart Lung Transplant 21:282–285

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, C3P, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands

    Simone A. Joosten, Cees van Kooten & Leendert C. Paul

Authors
  1. Simone A. Joosten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cees van Kooten
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leendert C. Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simone A. Joosten.

About this article

Cite this article

Joosten, S.A., van Kooten, C. & Paul, L.C. Pathogenesis of chronic allograft rejection. Transpl Int 16, 137–145 (2003). https://doi.org/10.1007/s00147-003-0554-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00147-003-0554-x

Keywords

Search

Navigation